Back to results
US 2015/0087672 A1Published application
Aromatic ring compound
AssigneeTakeda Pharmaceutical Company Limited
InventorsShizuo Kasai, Hideyuki Igawa, Masashi Takahashi, Asato Kina
Life of this patent
Estimating the term…
Abstract
The present invention provides an aromatic ring compound having a melanin-concentrating hormone receptor antagonistic action and useful as an agent for the prophylaxis or treatment of obesity and the like. The present invention relates to a compound represented by the formula wherein each symbol as defined in the specification, or a salt thereof.
Claims12
A compound represented by the formula:
- wherein
- ring AB is optionally further substituted;
- Ar1 is an optionally substituted 5- or 6-membered aromatic ring group;
- X1 is CR1 or N;
- X2 and X3 are each independently CH or N;
- one of Y1 and Y2 is a carbon atom and the other is a nitrogen atom;
- W is a bond, an optionally substituted C1-6 alkylene group, or an optionally substituted C2-6 alkenylene group;
- and
- R1 is a hydrogen atom, a halogen atom, an optionally substituted C1-6 alkyl group, an optionally substituted C3-10 cycloalkyl group or an optionally substituted C1-6 alkoxy group,
- or a salt thereof.
7 more elements
9-11. (canceled)
Dependencies are inferred from the claim text.